$0.77
▲ +2.0% Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026
SkinHealth Systems Inc. (SKIN) Upgraded to Strong Buy: Here's Why
SkinHealth Systems' SkinStylus Device Gets FDA Clearance for Periorbital Wrinkles
Overview
52-week range
$0.55
$2.69
10% of range
Avg surprise (last 3)
+79.1%
Avg reaction (last 2)
-7.6%
0% positive
Latest IV / EM
341%
EM ±78.0% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.05 | $-0.09 | +44.4% | +37.5% | -2.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.09 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.03 | $-0.06 | +150.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.08 | $-0.14 | +42.9% | — | -12.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.15 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.10 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.10 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.56 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.03 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.04 | $0.03 | -233.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | — | $71M | $78M | $70M | — | $79M | $91M |
| Cost of revenue | $20M | — | $25M | $29M | $21M | — | $38M | $50M |
| Gross profit | $44M | — | $46M | $49M | $49M | — | $41M | $41M |
| Operating income | $-2M | — | $-6M | $-3M | $-12M | — | $-22M | $-22M |
| Net income | $-7M | — | $-11M | $20M | $-10M | — | $-18M | $202,000 |
| EPS (diluted) | $-0.05 | — | $-0.09 | $0.03 | $-0.08 | — | $-0.15 | $-0.10 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $48M | $48M | $56M | $59M | $66M | $69M | $73M | $77M |
| Total current assets | $278M | $310M | $308M | $306M | $469M | $477M | $485M | $490M |
| Total assets | $473M | $500M | $504M | $508M | $674M | $686M | $700M | $712M |
| Long-term debt | — | — | $363M | $363M | — | $552M | — | — |
| Total liabilities | $418M | $439M | $438M | $434M | $628M | $634M | $640M | $643M |
| Total equity | $55M | $61M | $66M | $74M | $46M | $52M | $60M | $69M |